Britain may restrict heart pump use

November 29, 2006

British researchers are urging the restricted use of an implantable pump designed to help heart failure patients while they wait for a transplant.

"Although we believe that the devices have been developed sufficiently to prolong life for some very sick patients who have rapidly deteriorating heart failure, we don't feel they've been developed quite enough yet for widespread use among the whole heart failure population," said lead researcher Linda Sharples of Britain's National Health Service.

Sharples studied health outcomes and the cost effectiveness of the ventricular assist devices for 70 British patients who received the implant between April 2002 and December 2004.

"We compared the VAD group with the very sickest of the transplant candidates and found the healthcare for those individuals was less costly. Those non-VAD patients also had greater survival," Sharples said.

"We recommend that the United Kingdom continue to monitor the development of the new devices," said Sharples. "I think we are all quite hopeful that they will progress and we will have more cost-effective and effective devices in the future."

The review appears in the latest issue of Health Technology Assessment.

Copyright 2006 by United Press International

Explore further: Use of levosimendan with heart-lung machine fails to improve outcomes

Related Stories

Do you really have high blood pressure?

March 20, 2017

A study by researchers at the University of Montreal Hospital Research Centre (CRCHUM) shows that more than half of family doctors in Canada are still using manual devices to measure blood pressure, a dated technology that ...

Recommended for you

The ethics of tracking athletes' biometric data

January 18, 2017

(Medical Xpress)—Whether it is a FitBit or a heart rate monitor, biometric technologies have become household devices. Professional sports leagues use some of the most technologically advanced biodata tracking systems to ...

Study shows blood products unaffected by drone trips

December 7, 2016

In what is believed to be the first proof-of-concept study of its kind, Johns Hopkins researchers have determined that large bags of blood products, such as those transfused into patients every day, can maintain temperature ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.